tiprankstipranks
Trending News
More News >

BioAge Labs price target lowered to $5 from $7 at Citi

Citi analyst Samantha Semenkow lowered the firm’s price target on BioAge Labs (BIOA) to $5 from $7 and keeps a Neutral rating on the shares post the Q4 report. The firm anticipates the shares will remain somewhat range-bound over the next 12 months given “limited stock-moving catalysts.”

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1